REPO-TRIAL is getting ready to initiate REPO-STROKE, the first of its two Phase Ib/IIa investigator-initiated clinical trials investigating synergistic combinations of repurposed drugs. In this context the consortium published a press release with the topic ‘REPO-TRIAL PREPARES FOR ITS CLINICAL STUDY IN STROKE PATIENTS‘. Read more.
